|
ANKRD36 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.601300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.818300E-02 |
| Normal-vs-Stage2 |
2.24749999999663E-05 |
| Normal-vs-Stage3 |
7.102500E-03 |
| Normal-vs-Stage4 |
7.220300E-03 |
| Stage1-vs-Stage2 |
2.904600E-03 |
| Stage1-vs-Stage3 |
3.635600E-01 |
| Stage1-vs-Stage4 |
3.284000E-01 |
| Stage2-vs-Stage3 |
3.077700E-02 |
| Stage2-vs-Stage4 |
4.982100E-02 |
| Stage3-vs-Stage4 |
8.998200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.348300E-02 |
| Normal-vs-AfricanAmerican |
2.941600E-01 |
| Normal-vs-Asian |
1.139950E-01 |
| Caucasian-vs-AfricanAmerican |
5.522400E-01 |
| Caucasian-vs-Asian |
6.082600E-01 |
| AfricanAmerican-vs-Asian |
8.458600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.096820E-01 |
| Normal-vs-Female |
7.646500E-04 |
| Male-vs-Female |
9.368300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.494500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.860700E-03 |
| Normal-vs-Age(61-80Yrs) |
1.000970E-03 |
| Normal-vs-Age(81-100Yrs) |
6.197700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.016000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.183500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.603600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.012400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.981400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.973200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.500620E-01 |
| Classical-VS-Follicular |
1.404800E-04 |
| Classical-VS-Other |
5.659600E-01 |
| Classical-VS-Normal |
5.208000E-02 |
| Tall-VS-Follicular |
7.840100E-02 |
| Tall-VS-Other |
1.527640E-01 |
| Tall-VS-Normal |
7.518100E-03 |
| Follicular-VS-Other |
9.204000E-02 |
| Follicular-VS-Normal |
4.35210000000463E-05 |
| Other-VS-Normal |
8.152400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.350600E-04 |
| Normal-vs-N1 |
5.271600E-01 |
| N0-vs-N1 |
8.384800E-03 |
|
|
